PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.\', \'Center for Experimental Pharmacology and Toxicology (CPT), Central Animal Facility, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.\', \'Department of Neurology, JSS Hospital, Mysuru, Karnataka, India.\', \'Division of Cognitive Neuroscience and Psychology, Faculty of Life Sciences, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.\', \'The Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada.\', \'Department of Physiology, Al Faisal University, Riyadh, Saudi Arabia.\', \'Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.\', \'Department of Biomedical Sciences, Arthur Dugoni School of Dentistry, University of the Pacific, San Francisco, California, USA.\', \'Department of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan, 020000, Kazakhstan.\', \'Department of Food Science and Nutrition, CAMS, Sultan Qaboos University, Muscat, Oman.\', \'Principal Investigator, Ageing and Dementia Research Group, Sultan Qaboos University, Muscat, Oman.\', \'Research & Policy Department, World Innovation Summit for Health (WISH), Qatar Foundation, Doha, Qatar.\', \'Research & Policy Division, Q3CG Research Institute, Ypsilanti, Michigan, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/iid3.387
?:doi
?:hasPublicationType
?:journal
  • Immunity, inflammation and disease
is ?:pmid of
?:pmid
?:pmid
  • 33332737
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • 3
?:title
  • Does COVID-19 contribute to development of neurological disease?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all